Inspiratory Muscle Training on Glycemic Control in Individuals With Type 2 Diabetes

Diabetes Mellitus, Type 2 Clinical Trial

Official title:

Effect of Inspiratory Muscle Training on Glycemic Control in Individuals With Type 2 Diabetes:Randomized Clinical Trial

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT03191435
• Other study ID #: 61986916.9.0000.5327
• Status: Recruiting
• Phase: N/A
• First received: June 15, 2017
• Last updated: August 11, 2017
• Start date: July 11, 2017
• Est. completion date: January 31, 2019

Study information

• Verified date: August 2017
• Source: Hospital de Clinicas de Porto Alegre
• Contact: Beatriz D'Agord Schaan, PhD
• Phone: 55 51993138534
• Email: bschaan[@]hcpa.edu.br
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

In diabetic individuals, changes in ventilatory muscle strength and lung function have been demonstrated over the years. The onset and progression of chronic complications in diabetes should be avoided by reaching glycated hemoglobin (HbA1c) levels below 7%. The control of glycemia through the measurement of HbA1c is fundamental to avoid complications. The inspiratory muscle training has been used in several clinical situations, and may be an alternative for individuals with type 2 diabetes mellitus who have difficulties performing conventional exercises. The long-term effect of inspiratory muscle training on glycemic control has not been tested yet. The aim of this study is to evaluate the effects of inspiratory muscle training on glycemic control in individuals with type 2 diabetes.

Description:

An acute high intensity inspiratory muscle exercise session was able to reduce glycemic levels (24%) similarly to an aerobic exercise session (25%) in subjects with type 2 diabetes, demonstrating that this type of exercise inspiratory muscle may have great potential in improving glycemic control.The present study will investigate if training of the inspiratory musculature for 8 and 12 weeks is capable of improving glycated hemoglobin, glucose and inspiratory muscle strength in individuals with type 2 diabetes. In addition, this study will evaluate the effect of inspiratory muscle training, with moderate loading of 30% of the MIP, on volumes and capacities lung in patients with type 2 diabetes. The subjects with type 2 diabetes will be recruited from the ambulatory of the Hospital de Clinicas de Porto Alegre and through newspaper advertisements.

Patients will be submitted to a general evaluation, including clinical history, physical examination, laboratory evaluation and application of the international physical activity questionnaire. Subsequently, individuals will perform assessments of lung functions (lung function assessment, ventilatory muscle strength test, inspiratory muscle strength test) and autonomic assessment (Ewing's tests). Patients will be randomized to perform inspiratory muscle training with a placebo load (MIP 2%) or with moderate intensity (MIP 30%). Upon the randomization, participants will initiate inspiratory musculature training. The exams of HbA1c, glucose and ventilatory muscle strength tests will be performed in three moments: 1) at the initial assessment, 2) in the eighth week of inspiratory muscle training, and 3) at the end of the training (twelfth) week. During inspiratory muscle training, individuals will attend on Hospital de Clinicas de Porto Alegre, once a week, to the supervision of the way the exercise is being performed. Furthermore, it will be set to load on the PowerBreathe ® device for the following week.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 30
• Est. completion date: January 31, 2019
• Est. primary completion date: December 31, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 30 Years and older

Eligibility

Inclusion Criteria:

• Type 2 diabetes;

• 30 years and older;

• HbA1c from 7,5 to 10%.

Exclusion Criteria:

• Pregnant women;

• Pulmonary disease (chronic obstructive pulmonary disease, exercise-induced asthma, idiopathic pulmonary fibrosis, sarcoidosis and lung neoplasms);

• Neuromuscular disease;

• Body mass index > 35 kg/m²;

• Individuals who perform physical exercise more than twice a week;

• Current smoking.

Related Conditions & MeSH terms

• Diabetes Mellitus
• Diabetes Mellitus, Type 2
• Respiratory Aspiration

Intervention

Device:
• Inspiratory muscle training.
Patients will perform the inspiratory muscle training using a moderate load of 30% of maximal inspiratory pressure (MIP 30%). The training will be conducted at home in a period of 30 minutes, 7 times a week, during 12 weeks. During inspiratory muscle training, individuals will attend Hospital de Clinicas de Porto Alegre once a week to the supervision of the way the exercise is being performed. Furthermore, load in the device (powerbreathe) will be adjusted for the individual to use next week.
• Placebo inspiratory muscle
Patients will perform the inspiratory muscle training using a very low load of 2% of maximal inspiratory pressure (MIP 2%). The training will be conducted at home in a period of 30 minutes, 7 times a week, in the course of 12 weeks. During inspiratory muscle training, individuals will attend Hospital de Clinicas de Porto Alegre once a week to the supervision of the way the exercise is being performed.

Locations

Country	Name	City	State
Brazil	Hospital de Clínicas de Porto Alegre	Porto Alegre	Rio grande do sul

Sponsors (1)

Lead Sponsor	Collaborator
Hospital de Clinicas de Porto Alegre

Country where clinical trial is conducted

Brazil, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Glycated hemoglobin in 8 weeks	Glycated hemoglobin concentration after 8 weeks of inspiratory muscle training	Evaluated in 8 weeks of inspiratory muscle training
Primary	Glycated hemoglobin in 12 weeks	Glycated hemoglobin concentration after 12 weeks of inspiratory muscle training	Evaluated in 12 weeks of inspiratory muscle training
Secondary	Glucose in 8 weeks	Fasting plasma glucose concentration after 8 weeks of inspiratory muscle training.	Evaluated in 8 weeks of inspiratory muscle training
Secondary	Glucose in 12 weeks	Fasting plasma glucose concentration after 12 weeks of inspiratory muscle training.	Evaluated in 12 weeks of inspiratory muscle training
Secondary	Respiratory muscle strength in 8 weeks	Maximum respiratory muscle strength after 8 weeks of inspiratory muscle training, through the measurement of the maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP).	Evaluated in 8 weeks of inspiratory muscle training
Secondary	Respiratory muscle strength in 12 weeks	Maximum respiratory muscle strength after 12 weeks of inspiratory muscle training, through the measurement of the maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP).	Evaluated in 12 weeks of inspiratory muscle training
Secondary	Ventilatory muscle resistance	Muscular endurance ventilatory after 12 weeks of inspiratory muscle training, through analysis of the MIP.	Evaluated in 12 weeks of inspiratory muscle training
Secondary	Lung functions	Capacity and volumes lung after 12 weeks of inspiratory muscle training.	Evaluated in 12 weeks of inspiratory muscle training